Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.
Witta SE, Jotte RM, Konduri K, Neubauer MA, Spira AI, Ruxer RL, Varella-Garcia M, Bunn PA Jr, Hirsch FR. Witta SE, et al. Among authors: ruxer rl. J Clin Oncol. 2012 Jun 20;30(18):2248-55. doi: 10.1200/JCO.2011.38.9411. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508830 Free PMC article. Clinical Trial.
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma.
Bowles DW, Kochenderfer M, Cohn A, Sideris L, Nguyen N, Cline-Burkhardt V, Schnadig I, Choi M, Nabell L, Chaudhry A, Ruxer R, Ucar A, Hausman D, Walker L, Spira A, Jimeno A. Bowles DW, et al. Among authors: ruxer r. Clin Colorectal Cancer. 2016 Dec;15(4):337-344.e2. doi: 10.1016/j.clcc.2016.03.004. Epub 2016 Mar 31. Clin Colorectal Cancer. 2016. PMID: 27118441 Clinical Trial.
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.
Hutson TE, Vukelja S, Atienza D, Awasthi S, Delaune R, Deutsch M, Dien PY, Gregory TF, Kolodziej MJ, Muscato JJ, Raju RN, Ruxer RL Jr, Mull S, Ilegbodu D, Hood K, Nicol S, Berry W. Hutson TE, et al. Among authors: ruxer rl jr. Invest New Drugs. 2008 Apr;26(2):151-8. doi: 10.1007/s10637-007-9111-2. Epub 2008 Jan 31. Invest New Drugs. 2008. PMID: 18236006 Clinical Trial.
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
Cartwright T, Kuefler P, Cohn A, Hyman W, Berger M, Richards D, Vukelja S, Nugent JE, Ruxer RL Jr, Boehm KA, Asmar L. Cartwright T, et al. Among authors: ruxer rl jr. Clin Colorectal Cancer. 2008 Nov;7(6):390-7. doi: 10.3816/CCC.2008.n.052. Clin Colorectal Cancer. 2008. PMID: 19036692 Clinical Trial.
Mesothelioma following Wilms' tumor in childhood.
Antman KH, Ruxer RL Jr, Aisner J, Vawter G. Antman KH, et al. Among authors: ruxer rl jr. Cancer. 1984 Jul 15;54(2):367-9. doi: 10.1002/1097-0142(19840715)54:2<367::aid-cncr2820540232>3.0.co;2-y. Cancer. 1984. PMID: 6327010
17 results